ClinicalTrials.gg
Enrolling by invitationNCT07005375Updated Jun 8, 2025

The Effect of Bathing in the Thermal Mineral Water on the Pain and Performance of Athletes

An interventional study of thermal mineral water bath in Low Back Pain, Fatigue Recovery and Performance Measures, sponsored by Polyclinic of the Hospitaller Brothers of St. John of God, Budapest. Enrolling by invitation at 1 site in Hungary. Open to participants aged 14 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-08.

Sponsored by Polyclinic of the Hospitaller Brothers of St. John of God, Budapest · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as enrolling by invitation.
  • Registered 9 months after the study started (first participant enrolled Jul 2024, registered Apr 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
14 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Low Back Pain with a site in Hungary — 1 open to participants now, 3 under way, 1 of them phase 3. Low Back Pain · Hungary.

Planned enrollment
9th of 10
30 · median 225
Started
2024
the only one that year
No phase
6 of 14
1 open now
Registered
14th of 14
by date
Lead sponsor
4 of 14
Polyclinic of the Hospitaller Brothers of St. John of God, Budapest

Among the 14 studies in Low Back Pain with a site in Hungary, this one is the 9th largest by planned enrollment of the 10 interventional ones that give a count, is the only one that started in 2024, is one of 6 with no phase, and was the 14th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

1 of the 14 studies in Low Back Pain with a site in Hungary is open now.

A study can be open while its sites in Hungary have not opened yet or have stopped. Only those recruiting at a site in Hungary →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 14 Years to 75 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Low Back Pain with a site in Hungary, or all of them as a file.
02

Study summary

Effect of bathing in the thermal mineral water well on the performance and potential pain of athletes. Randomized, controlled, single-blind study.

Read the detailed description

In rowing sports, where the same series of movements are repeated thousands of times, the lower lumbar region is the most stressed part. Because of this, even training on an ergometer can cause numerous lower back problems, even among competitors. In addition, rowers use many muscle groups during their sport, for which the beneficial effect of thermal medicinal waters, affecting the entire musculoskeletal system, can be beneficial, and is used for rehabilitation purposes in several countries.

Studies describe the numerous positive effects of bathing in warm water (37-46°C) in increasing blood flow, regulating blood sugar, and even the positive response of the vascular system.

The Palatinus Spa's water supply is provided by the drilled thermal wells of Margit Island of Budapest.

Regarding its type, the medicinal water is a low salt concentration, calcium-magnesium-hydrogen carbonate, chloride, and sulfate medicinal water, which also has a significant fluoride and metasilicic acid content. The total dissolved mineral content is 1205 mg/liter. In the study, we would conduct the clinical trial necessary for the "Margaret Island mineral water" / 37-38 °C / thermal mineral water of the Margitszigeti É. III well to be declared medicinal water.

Research Question Primary objective: Effect of bathing in the "Margaret Island mineral water" thermal mineral water of the Margaret Island III well on the performance and potential pain of athletes. Randomized, controlled, single-blind study.

Secondary objective: To what extent does thermal water treatment lead to a change in the quality of life of those receiving it compared to their initial condition, and what is the magnitude of this change compared to the control group?

03

Conditions studied

  • Low Back Pain
  • Fatigue Recovery
  • Performance Measures

Keywords

  • low back pain, fatigue
  • performance
04

Who can participate

Ages eligible
14 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Rowers coming from the surrounding area, with registration at the Hungarian Rowing Federation (MESZ), including competitive/touring and recreational/masters rowers
  • Women and men between 18 and 75 years of age
  • Participating in regular training for at least 6 months
  • Signed form prior to the start of the study

Exclusion criteria

Exclusion Criteria:

  • Acute pain;
  • Organic neurological deficit;
  • in the background;
  • Pain attributable to inflammatory disease;
  • Participants must not have received systemic or local therapy, physiotherapy as a course of treatment, massage therapy, or balneotherapy as a course of treatment within 3 months prior to the study;

General of balneotherapy:

  • unstable angina pectoris,
  • uncontrolled hypertension,
  • cardiac decompensation,
  • respiratory failure,
  • unbalanced endocrinological disease,
  • acute febrile condition,
  • infectious skin diseases,
  • other serious internal, urogenital, and other diseases, urinary and fecal incontinence,
  • decompensated psychosis and neurosis, lack of compliance
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Athletes/rowing

    Patients were enrolled if they met the inclusion and exclusion criteria. The classification would be based on a randomization list. Measurements, clinical examinations, and evaluation of pain and functional status-related quality of life will be performed before, immediately after the treatments, and 3 months later. One group will bathe in a pool filled with 36°C thermal mineral water of the Palatinus Spa for 3 weeks, 5 days a week, for a total of 15 sessions, 20 minutes per session. Bathing in the thermal mineral water takes place in the medicinal water pool. The control group does not receive balneotherapy. Both groups can continue their usual training plan. The thermal mineral water-treated group and the control group may not receive systemic or locally administered steroid therapy during the study, and the control group may not receive balneotherapy.

    Behavioral: thermal mineral water bath

  • Active comparator
    Athletes

    One group will bathe in a pool filled with 36°C thermal mineral water of the Palatinus Spa for 3 weeks, 5 days a week, for a total of 15 sessions, 20 minutes per session. Bathing in the thermal mineral water takes place in the medicinal water pool. The control group does not receive balneotherapy. Both groups can continue their usual training plan. Rowers coming from the surrounding area, with registration at the Hungarian Rowing Federation

    Behavioral: thermal mineral water bath

Interventions

  • Behavioralthermal mineral water bath

    One group will bathe in a pool filled with 36°C thermal mineral water of the Palatinus Spa for 3 weeks, 5 days a week, for a total of 15 sessions, 20 minutes per session. Bathing in the thermal mineral water takes place in the medicinal water pool. The control group does not receive balneotherapy. Both groups can continue their usual training plan.

    Also known as: water, thermal water, mineral water

06

What researchers measure

Primary outcomes

  1. The extent of the effect and change on the performance of athletes and any existing pain in the balneotherapy group compared to the change in the control group. This would be measured by the improvement in 6000-meter ergometer performance.

    The extent of the effect and change on the performance of athletes and any existing pain in the balneotherapy group compared to the change in the control group. This would be measured by the improvement in 6000-meter ergometer performance. Examining the change in threshold load with improving parameters and heart rate variability (HRV) (examining how the heart is able to continuously change the duration between heartbeats (RR intervals) in response to changes in internal and external environmental loads, and thereby showing the heart's adaptation. This adaptability of the heart is based on the optimal interplay and cooperation of the sympathetic and parasympathetic nervous systems.)

    Time frame: 3 months

Secondary outcomes

  1. The extent of the change in fatigue, muscle pain, and discomfort between workouts measured by VAS in the balneotherapy group compared to the change in the control group.

    The extent of the change in fatigue, muscle pain, and discomfort between workouts measured by 1-10 points on a VAS in the balneotherapy group compared to the change in the control group. Change in lumbar spine movement function in cm. Specific questionnaire for lower back pain (Oswestry) Quality of life questionnaire (EuroQuol-5D-5L) Change in medication therapy used for pain. The extent of change on the Borg scale 0-10 points (How much did you exert yourself?)

    Time frame: 3 months

07

Study locations

1 site
  • Hospital Budai Irgalmasrendi Kórház Nonprofit Kft.
    Budapest, 1027, Hungary
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Dec 2025, 17 months after the start.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 17 months is above that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 21, 2025
First posted
Jun 5, 2025
StartActual
Jul 1, 2024
Primary completionEst.
Dec 11, 2025
CompletionEst.
Dec 31, 2025
Last update
Jun 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07005375
Lead sponsor
Polyclinic of the Hospitaller Brothers of St. John of God, Budapest
Responsible party
Tamas Gati (MD, Polyclinic of the Hospitaller Brothers of St. John of God, Budapest) — Principal investigator
First posted
Jun 5, 2025
Start date
Jul 1, 2024
Primary completion
Dec 11, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Jun 8, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion